Recommended Research Articles
Arter, S., Lambert, J., Brokman, A., & Fall, N. (2021). Diagnoses during the First Three Years of Life for Children with Prenatal Opioid Exposure and Neonatal Abstinence Syndrome Using a Large Maternal Infant Data Hub. Journal of Pediatric Nursing, 61(1) 34-39. https://doi.org/10.1016/j.pedn.2021.03.011
Arter, S. J., Tyler, B., McAllister, J., Kiel, E., Güler, A., & Cameron Hay, M. (2021). Longitudinal Outcomes of Children Exposed to Opioids In‐utero: A Systematic Review. Journal of Nursing Scholarship, 53(1), 55–64. https://doi.org/10.1111/jnu.12609
Boyd, R. (2018). Foster care outcomes and experiences of infants removed due to substance abuse. Journal of Public Child Welfare, 13(5), 529-555. doi:10.1080/15548732.2018.1536627
Cochran, J. D., Jarrett, T., & Baus, A. (2020). Characteristics of Neonatal Abstinence Syndrome in a Rural Clinic Population: Using Electronic Medical Health Records for Tracking. Online Journal of Rural Nursing & Health Care, 20(2), 194–212. https://doi.org/10.14574/ojrnhc.v20i2.625
Cook, C. E., & Fantasia, H. C. (2019). Interventions for the Treatment of Neonatal Abstinence Syndrome. Nursing for Women’s Health, 23(4), 357–365. https://doi.org/10.1016/j.nwh.2019.05.006
Creanga, A., Sabel, J. C., Ko, J.Y., Wasserman, C. R., Shapiro-Mendoza, C. K., Taylor, P., Barfield, W., Cawthon, L., & Paulozzi, L.J. (2012). Maternal drug use and its effect on neonates: A population-based study in Washington State. Obstet Gynecol. 119(5), 24-33. https://doi.org/10.1097/AOG.0b013e31824ea276
Fucile, S., Gallant, H., & Patel, A. (2021). Developmental Outcomes of Children Born with Neonatal Abstinence Syndrome (NAS): A Scoping Review. Physical & Occupational Therapy in Pediatrics, 41(1), 85–98. https://doi.org/10.1080/01942638.2020.1766637
Gottlieb, J.D., Davies, T., & Wright, S. (2019). Healthy Connections: Helping Families in West Virginia Combat Opioid Addiction. Children’s Voice, 28(1), 8–10. https://www.cwla.org/healthy-connections-helping-families-in-west-virginia-combat-opioid-addiction/
Hirai A.H., Ko J.Y., Owens P.L., Stocks C., Patrick, S.W. (2021). Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017. JAMA, 325(2): 146–155. doi:10.1001/jama.2020.24991
Ko, J. Y., Patrick, S. W., Tong, V. T., Patel, R., Lind, J. N., & Barfield, W. D. (2016). Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013. MMWR Morb Mortal Wkly Rep, 65(31), 799- 802. doi:10.15585/mmwr.mm6531a2
MacMullen, N. J., Dulski, L. A., & Blobaum, P. (2014). Evidence-based interventions for neonatal abstinence syndrome. Pediatric nursing, 40(4), 165–203. https://pubmed.ncbi.nlm.nih.gov/25269356/
McCarty, T & Braswell, E. (2022). Implementation of Interprofessional Rounds Decreases Neonatal Abstinence Syndrome Length of Stay. The Journal of Pediatric Pharmacology and Therapeutics 27 (2): 157–163. doi: https://doi.org/10.5863/1551-6776-27.2.157
Modernel Xavier, D., Calcagno Gomes, G., Portella Ribeiro, J., Soares Mota, M., & Quadros Alvarez, S. (2017). Use of crack in pregnancy: repercussions for the newborn. Investigacion & Educacion En Enfermeria, 35(3), 260–267. https://doi.org/10.17533/udea.iee.v35n3a02
Patrick, S. W., Dudley, J., Martin, P.R., Harrell, F.E., Warren, M.D., Hartmann, K. E., Ely, E. W., Grijalva, C. G., & Cooper, W. O.. (2015). Prescription Opioid Epidemic and Infant Outcomes. Pediatrics, 135(5), 842–850. https://doi.org/10.1542/peds.2014-3299
Seiger, M. H. & Becker, J. (2020). Neonatal Abstinence Syndrome and Trends in Infant Foster Care Admissions. Child Welfare, 98 (3): 121-143. https://go.gale.com/ps/i.do?p=HRCA&u=googlescholar&id=GALE|A656271083&v=2.1&it=r&sid=googleScholar&asid=b9113467